Adi Kartolo

Hamilton, ON L8S4L8, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications

Evaluating the Utility and Implementation Barriers of a Liquid Biopsy Biomarker Test Early in the Lung Cancer Diagnostic Pathway to Improve Timeliness of Palliative Systemic Therapy.

Evaluating the Utility and Implementation Barriers of a Liquid Biopsy Biomarker Test Early in the Lung Cancer Diagnostic Pathway to Improve Timeliness of Palliative Systemic Therapy.

Journal: Current oncology (Toronto, Ont.)
Published: November 27, 2025

Resectable locally advanced head and neck squamous cell carcinoma: cut first or immune checkpoint inhibitors first?

Resectable locally advanced head and neck squamous cell carcinoma: cut first or immune checkpoint inhibitors first?

Journal: Oral oncology
Published: September 16, 2025

Prognostic factors in advanced incurable HNSCC patients on palliative-intent immunotherapy-based regimen.

Prognostic factors in advanced incurable HNSCC patients on palliative-intent immunotherapy-based regimen.

Journal: Future science OA
Published: August 28, 2025

Meaningful efficacy measures and trial endpoints in patients with advanced melanoma being considered for adjuvant systemic therapy: a prospective patient survey study.

Meaningful efficacy measures and trial endpoints in patients with advanced melanoma being considered for adjuvant systemic therapy: a prospective patient survey study.

Journal: Melanoma research
Published: August 15, 2025

Therapeutic lymph node dissection with neoadjuvant immunotherapy for macroscopic melanoma - too much skin in the game?

Therapeutic lymph node dissection with neoadjuvant immunotherapy for macroscopic melanoma - too much skin in the game?

Journal: Immunotherapy
Published: July 01, 2025

Time toxicity of nivolumab in metastatic head and neck squamous cell carcinoma patients: a single-institution experience.

Time toxicity of nivolumab in metastatic head and neck squamous cell carcinoma patients: a single-institution experience.

Journal: Immunotherapy
Published: June 13, 2025

Induction chemotherapy and immunotherapy followed by chemo-radiotherapy in incurable advanced head and neck squamous cell carcinoma: A case-series.

Induction chemotherapy and immunotherapy followed by chemo-radiotherapy in incurable advanced head and neck squamous cell carcinoma: A case-series.

Journal: Oral oncology
Published: May 14, 2025

Efficacy and safety of adjuvant systemic therapies in trial non-eligible resected stages III and IV melanoma patients.

Efficacy and safety of adjuvant systemic therapies in trial non-eligible resected stages III and IV melanoma patients.

Journal: Melanoma management
Published: February 17, 2025

Concurrent immunotherapy and radiation in cisplatin-ineligible patients with HNSCC: a systematic review & meta-analysis.

Concurrent immunotherapy and radiation in cisplatin-ineligible patients with HNSCC: a systematic review & meta-analysis.

Journal: Immunotherapy
Published: December 06, 2024

Association of circadian timing of initial infusions of immune checkpoint inhibitors with survival in advanced melanoma.

Association of circadian timing of initial infusions of immune checkpoint inhibitors with survival in advanced melanoma.

Journal: Immunotherapy
Published: May 16, 2023

Management of metastatic head and neck Cancer: An all-in, kitchen-sink Approach?

Management of metastatic head and neck Cancer: An all-in, kitchen-sink Approach?

Journal: Oral oncology
Published: April 28, 2023

Survival outcomes and predicting intracranial metastasis in stage III non-small cell lung cancer treated with definitive chemoradiation: Real-world data from a tertiary cancer center.

Survival outcomes and predicting intracranial metastasis in stage III non-small cell lung cancer treated with definitive chemoradiation: Real-world data from a tertiary cancer center.

Journal: Cancer treatment and research communications
Published: March 27, 2023
Showing 1-12 of 39

Last Updated: 09/26/2026